TECARTUS™ (brexucabtagene autoleucel) is a treatment for your mantle cell lymphoma.Read more +

Read more +

TECARTUS™ (brexucabtagene autoleucel) is a treatment for your mantle cell lymphoma. It is used following disease progression while on or after other treatment. TECARTUS is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.Read less -

+
Medication Guide
TECARTUS™ logo TECARTUS™ logo
  • Home
  • About
    MCL
  • About CAR T
    and TECARTUS
    About CAR TWhat is TECARTUS?How TECARTUS is DifferentTECARTUS Treatment Process
  • TECARTUS
    Results
  • Side
    Effects
  • Authorized
    Treatment Centers
  • Patient
    Support
  • Indication
  • Medication Guide
  • Important Safety Information
  • For Healthcare Professionals

Home / Site Map

Site map

Home

About MCL

About CAR T and TECARTUS

About CAR T

What is TECARTUS?

How TECARTUS is Different

TECARTUS Treatment Process

TECARTUS Results

Side Effects

Authorized Treatment Centers

Patient Support

Back to Home
View more View less

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about TECARTUS?

TECARTUS may cause side effects that are life-threatening and can lead to death. Call or see your doctor or get emergency help right away if you get any of the following:

  • Fever (100.4°F/38°C or higher)
  • Difficulty breathing
  • Chills or shaking chills
  • Confusion
  • Dizziness or lightheadedness
  • Severe nausea, vomiting, or diarrhea
  • Fast or irregular heartbeat
  • Severe fatigue or weakness

It is important to tell your healthcare provider that you received TECARTUS and to show them your TECARTUS Patient Wallet Card. Your healthcare provider may give you other medicines to treat your side effects.

Before getting TECARTUS, tell your healthcare provider about all your medical problems, including if you have or have had:

  • Neurologic problems (such as seizures, stroke, or memory loss)
  • Lung or breathing problems
  • Heart problems
  • Liver problems
  • Kidney problems
  • A recent or active infection

Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive TECARTUS?

  • Since TECARTUS is made from your own white blood cells, your blood will be collected by a process called “leukapheresis” (loo-kah-fur-ee-sis), which will concentrate your white blood cells.
  • Your blood cells will be sent to a manufacturing center to make your TECARTUS.
  • Before you get TECARTUS, you will get 3 days of chemotherapy to prepare your body.
  • When your TECARTUS is ready, your healthcare provider will give it to you through a catheter placed into your vein (intravenous infusion). The infusion usually takes less than 30 minutes. You will be monitored where you received your treatment daily for at least 7 days after the infusion.
  • You should plan to stay close to the location where you received your treatment for at least 4 weeks after getting TECARTUS. Your healthcare provider will help you with any side effects that may occur.
  • You may be hospitalized for side effects and your healthcare provider will discharge you if your side effects are under control, and it is safe for you to leave the hospital.
  • Your healthcare provider will want to do blood tests to follow your progress. It is important that you do have your blood tested. If you miss an appointment, call your healthcare provider as soon as possible to reschedule.

What should I avoid after receiving TECARTUS?

  • Do not drive, operate heavy machinery, or do other dangerous things for 8 weeks after you get TECARTUS because the treatment can cause sleepiness, confusion, weakness, temporary memory and coordination problems.
  • Do not donate blood, organs, tissues, and cells for transplantation.

What are the possible or reasonably likely side effects of TECARTUS?

The most common side effects of TECARTUS include:

  • Fever (100.4°F/38°C or higher)
  • Low white blood cells (can occur with a fever)
  • Low red blood cells
  • Low blood pressure (dizziness or lightheadedness, headache, feeling tired, short of breath)
  • Fast heartbeat
  • Confusion
  • Difficulty speaking or slurred speech
  • Nausea
  • Diarrhea

These are not all the possible side effects of TECARTUS. Call your healthcare provider about any side effects that concern you. You may report side effects to the FDA at 1-800-FDA-1088.

Please see Medication Guide about TECARTUS, including important warnings.

APPROVED USE

TECARTUS is a treatment for your mantle cell lymphoma. It is used following disease progression while on or after other treatment. TECARTUS is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.

Back to top
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map

The content of this site is intended for US residents only.

The content on this site may not apply to non-US audiences as regulatory control, legal requirements, and/or medical practices may vary in other countries.

TECARTUS, the TECARTUS Logo, KITE KONNECT, the KITE KONNECT Logo, KITE, and the KITE Logo are trademarks of Kite Pharma, Inc. GILEAD is a trademark of Gilead Sciences, Inc. All other trademarks referenced herein are the property of their respective owners.

© 2020 Kite Pharma, Inc. All rights reserved. | TECC0008 08/2020

Kite logo

You are now leaving the TECARTUS™ (brexucabtagene autoleucel) website.

Kite Pharma is not responsible for the information contained in any of the linked sites.

Cancel
OK

You are now leaving TECARTUS.com.

Select CANCEL to return or OK to continue.

Cancel
OK

You are going to a website that contains clinical information and was created specifically for healthcare professionals. If you are not a healthcare professional and would like to return to the consumer site, please click CANCEL.

Cancel
Continue